A Closer Look at Parkinson’s Care This April

April is Parkinson’s Awareness Month, and at The Remedy Group, we’re highlighting a condition that affects nearly 1 million people in the U.S. and more than 10 million worldwide.

And that number continues to rise.

With an aging population and improved diagnosis, Parkinson’s is becoming an increasingly important focus across neurology, specialty pharmacy, and infusion care.

What Many People Don’t Realize About Parkinson’s

There’s a lot more to Parkinson’s than what most people see. It’s not just tremors. While tremors are the most recognized symptom, many patients struggle just as much (or more) with non-motor symptoms like:

• Sleep disturbances
• Depression and anxiety
• Cognitive changes
• Gastrointestinal issues

These often go underdiagnosed, but can significantly impact quality of life.

A Few Key Stats to Know

• ~90,000 new cases of Parkinson’s are diagnosed in the U.S. each year
• The number of people living with Parkinson’s is projected to increase significantly by 2030.
• Parkinson’s is the second most common neurodegenerative disease after Alzheimer’s
• Many patients experience progressive motor + non-motor symptoms that require long-term, evolving care strategies

What is the Conection to Specialty Pharmacy & Infusion?

Parkinson’s care isn’t one-size-fits-all.

As the disease progresses, patients often transition from oral therapies to more advanced treatment options, including:

• Continuous infusion therapies
• Complex medication regimens requiring close monitoring
• Specialty medications with strict handling, storage, and distribution requirements

This is where specialty pharmacy and infusion providers play a critical role:

• Coordinating therapy initiation and education
• Managing prior authorizations and payer requirements
• Supporting adherence through ongoing patient engagement
• Acting as a bridge between neurologists, caregivers, and patients

In many cases, access to these therapies can directly impact quality of life and symptom control.

What Are Providers Doing to Improve Access & Care?

Across the industry, we’re seeing providers take a more proactive, patient-centered approach to Parkinson’s care:

• Navigating payer complexity early – verifying benefits, handling prior authorizations, and anticipating coverage barriers before they delay care

• Strengthening referral networks – building close relationships with neurologists, movement disorder specialists, and care teams to streamline access

• Investing in patient education by helping patients and caregivers understand therapy options, administration, and expectations

• Coordinating with nurses, pharmacists, and support staff to ensure continuity of care

• Expanding site-of-care options – offering home infusion or alternate care settings to improve convenience and adherence

Why Does This Matter?

For Parkinson’s patients, timing, access, and coordination can make all the difference.

And as therapies continue to evolve, the role of specialty pharmacy and infusion providers will only become more important in:

• Reducing barriers to care
• Supporting long-term disease management
• Improving overall patient outcomes

Awareness is important, but access is what truly drives impact.

This month is a reminder of the work being done across healthcare to better support Parkinson’s patients and the opportunity ahead to continue improving how care is delivered.